Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02620423
Title Study of Pembrolizumab With REOLYSIN and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncolytics Biotech
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine

Fluorouracil

Irinotecan

Pelareorep

Leucovorin

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.